These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3678785)

  • 21. [Scintillation counting as an in vitro method for assessing the pretherapeutic effectiveness of planned tumor chemotherapy in patients with ovarian cancer].
    Behling H; Krafft W; Wagner F
    Zentralbl Gynakol; 1987; 109(1):42-8. PubMed ID: 3577462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.
    Gong Y; Booser DJ; Sneige N
    Cancer; 2005 May; 103(9):1763-9. PubMed ID: 15786420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
    Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Normalization of in vitro sensitivity testing of human tumor clonogenic cells.
    Hug V; Thames H; Blumenschein GR; Spitzer G; Drewinko B
    Cancer Res; 1984 Mar; 44(3):923-8. PubMed ID: 6692414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18.
    Fisher ER; Wang J; Bryant J; Fisher B; Mamounas E; Wolmark N
    Cancer; 2002 Aug; 95(4):681-95. PubMed ID: 12209710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pretherapeutic chemosensitivity testing of ovarian cancer and possibilities for its clinical use].
    Hernádi Z; Pásti G; Lampé L; Juhász B
    Zentralbl Gynakol; 1985; 107(17):1065-71. PubMed ID: 4060913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
    Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
    J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
    Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical experiences with in vitro testing of chemotherapeutic agents].
    Axhausen M; Matthias R
    HNO; 1985 Aug; 33(8):374-6. PubMed ID: 2412996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [-Chemosensitivity testing in gynecologic oncology. Experiences with an ATP bioluminescence assay-].
    Kurbacher CM; Mallmann P; Kurbacher JA; Hübner H; Krebs D
    Geburtshilfe Frauenheilkd; 1996 Feb; 56(2):70-8. PubMed ID: 8647362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Short-term incubation in vitro with precursors of nucleic acids on human primary tumors and metastases of carcinoma of the breast (author's transl)].
    Kaufmann M; Kubli F; Volm M; von Fournier D; Reus W
    Strahlentherapie; 1978 Apr; 154(4):277-81. PubMed ID: 644602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of tritiated nucleotide incorporation for prediction of sensitivity of tumors to cytostatic agents.
    Volm M
    Behring Inst Mitt; 1984 May; (74):273-84. PubMed ID: 6383325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biologic tumor markers, lymph node status, and decision about adjuvant chemotherapy for breast cancer.
    Velanovich V
    Am Surg; 1997 Apr; 63(4):330-3. PubMed ID: 9124752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy.
    Gasparini G; Barbareschi M; Boracchi P; Verderio P; Caffo O; Meli S; Dalla Palma P; Marubini E; Bevilacqua P
    Cancer J Sci Am; 1995; 1(2):131-41. PubMed ID: 9166466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer.
    Foekens JA; Peters HA; Grebenchtchikov N; Look MP; Meijer-van Gelder ME; Geurts-Moespot A; van der Kwast TH; Sweep CG; Klijn JG
    Cancer Res; 2001 Jul; 61(14):5407-14. PubMed ID: 11454684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant systemic therapy for lymph node-negative breast cancer less than or equal to 1 cm.
    Russell CA
    Curr Womens Health Rep; 2002 Apr; 2(2):134-9. PubMed ID: 12116603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low levels of estrogen receptor beta protein predict resistance to tamoxifen therapy in breast cancer.
    Hopp TA; Weiss HL; Parra IS; Cui Y; Osborne CK; Fuqua SA
    Clin Cancer Res; 2004 Nov; 10(22):7490-9. PubMed ID: 15569979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast.
    Visscher DW; Zarbo RJ; Greenawald KA; Crissman JD
    Pathol Annu; 1990; 25 Pt 1():171-210. PubMed ID: 2153277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In-vitro testing of the sensitivity of mammary carcinoma cells to cytostatic drugs (author's transl)].
    Bastert G; Schmidt-Matthiesen H; Gerner R; Michel RT; Nord D; Leppien G
    Dtsch Med Wochenschr; 1975 Oct; 100(40):2035-42. PubMed ID: 1157720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chemosensitivity studies with soft agar culture systems in ovarian cancer].
    Werner A; Krebs D; Diedrich K; Fimmers R; Heuer J; Oberheuser F
    Geburtshilfe Frauenheilkd; 1990 Nov; 50(11):883-9. PubMed ID: 2283015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.